Retinai connect
to Appway

Welcome to the RetinAI AppWay Gateway

RetinAI offers a set of Applications to be used in Heidelberg Engineering's AppWay for your convenience.

  • nAMD Application
  • DME Application
  • dry AMD Application
  • Degenerative Macular Disease Application
  • Cystoid Macular Edema Application

Interested in trying the
RetinAI AppWay Applications?

Register to RetinAI Apps

Need support with the
RetinAI AppWay Applications?

Contact Support

Read our Terms & Conditions or the RetinAI Apps Information page if you want to know more.


RetinAI Discovery is a CE-marked medical device according to the Medical Devices Regulation (EU) 2017/745
and the AI models are CE-marked devices according to Medical Devices Directive 93/42/EEC
RetinAI Discovery® is a 510(k) FDA Cleared medical device in US.
RetinAI Discovery® and Retinai® are both trademarks of RetinAI Medical AG.

The AI modules for biomarkers, fluid and layer segmentation and quantification
in retinal pathologies are for research use only in the USA.
The Advanced Segmentation and GA modules are for research use only.
Please be advised these tools are not intended to be a substitute for medical advice, diagnosis or treatment.
We do not warrant any reliance on the accuracy, completeness or usefulness of any content.